www.rupeedesk.in
Stocks of major pharmaceutical companies are seen moving in a range with no specific trigger seen next week. Most of them will remain in a range bound kind of thing. This week because of some warning letters, there was some subduedness but that has recovered now. Jubilant LifeSciences Ltd was issued a warning letter by US Food and Drug Administration for its Washington unit for violation of good manufacturing norms. As per the (company) management, the issues raised by the US FDA are largely relating to SOP (standard operating procedure) and not very serious in nature. While the business from this unit currently remains unaffected. The support levels for Sun Pharmaceutical Industries Ltd, and Lupin Ltd are crucial, as these are heavyweight pharma stocks.
Stocks of major pharmaceutical companies are seen moving in a range with no specific trigger seen next week. Most of them will remain in a range bound kind of thing. This week because of some warning letters, there was some subduedness but that has recovered now. Jubilant LifeSciences Ltd was issued a warning letter by US Food and Drug Administration for its Washington unit for violation of good manufacturing norms. As per the (company) management, the issues raised by the US FDA are largely relating to SOP (standard operating procedure) and not very serious in nature. While the business from this unit currently remains unaffected. The support levels for Sun Pharmaceutical Industries Ltd, and Lupin Ltd are crucial, as these are heavyweight pharma stocks.
